Revenue, last quarter
$0
Net income
−$14.6M
−409.9% vs same quarter last year
EPS, diluted
−$0.07
+81.6% vs same quarter last year
Operating cash flow
−$11.8M
−231% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $0 | −$16.8M |
| FY24 | $0 | −$14.4M |
| FY23 | $250K | −$12.3M |
| FY22 | $0 | −$14.3M |
| FY21 | - | −$26.6M |
| FY20 | $13.5K | −$10.3M |
| FY19 | $15.4K | −$8.4M |
| FY18 | $260K | −$4.9M |
| FY17 | $260K | −$15.7M |
| FY16 | $16.2K | −$21.1M |
| FY15 | $10.4K | −$20.9M |
| FY14 | $18.8K | −$22.6M |
| FY13 | $110K | −$19.8M |
| FY12 | $407.7K | −$10.1M |
| FY11 | $390.6K | −$12.5M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | - | - |
| FY24 | - | - |
| FY23 | −5228% | −4920% |
| FY22 | - | - |
| FY21 | - | - |
| FY20 | −68764.8% | −76346.2% |
| FY19 | −56071.8% | −54252.6% |
| FY18 | −3176.7% | −1894.1% |
| FY17 | −5118.1% | −6025.4% |
| FY16 | −127027.2% | −129721.8% |
| FY15 | −183896.8% | −200671% |
| FY14 | −92581.4% | −120154.7% |
| FY13 | −11385.4% | −18029% |
| FY12 | −2491.1% | −2482.5% |
| FY11 | −3325.6% | −3204.7% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | −$12.2M |
| FY23 | −$11.1M |
| FY22 | −$13.4M |
| FY21 | −$14.8M |
| FY20 | −$4.8M |
| FY19 | - |
| FY18 | −$7.7M |
| FY17 | −$13.4M |
| FY16 | −$15.7M |
| FY15 | −$19.1M |
| FY14 | −$11.9M |
| FY13 | −$10.7M |
| FY12 | −$8.5M |
| FY11 | −$8.3M |
- Palisade Bio
- Healthcare median
Show the numbers
| Year | Palisade Bio | Healthcare median |
|---|---|---|
| FY25 | - | −30.6% |
| FY24 | - | −47% |
| FY23 | −4920% | −58% |
| FY22 | - | −80.4% |
| FY21 | - | −71.8% |
| FY20 | −76346.2% | −62.2% |
| FY19 | −54252.6% | −46.2% |
| FY18 | −1894.1% | −49.6% |
| FY17 | −6025.4% | −45.9% |
| FY16 | −129721.8% | −36% |
| FY15 | −200671% | −37.8% |
| FY14 | −120154.7% | −35.5% |
| FY13 | −18029% | −37.1% |
| FY12 | −2482.5% | −29.1% |
| FY11 | −3204.7% | −27.9% |